AGIOS PHARMACEUTICALS, INC. - 8-K Filing
Agios Pharmaceuticals reports Q3 2026 mitapivat revenue of $55.4 million, a fourfold increase YoY, and targets non-GAAP profitability in 2028.
Tickers: $AGIO
More Regulatory news
- SAGA COMMUNICATIONS INC - 8-K Filing
- NextBoat Inc. - 8-K Filing
- CIVISTA BANCSHARES, INC. - 8-K Filing
- RF Acquisition Corp II - 10-Q Filing
- ORASURE TECHNOLOGIES INC - 10-Q Filing
- Rocket Companies, Inc. - 8-K Filing
- Applied Aerospace & Defense, Inc. - 10-Q Filing
- Palomar Holdings, Inc. - 8-K Filing
- UNITED GUARDIAN INC - 10-Q Filing
- Dare Bioscience, Inc. - 8-K Filing